Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway

Journal of Surgical Oncology

Volumn 100, Issue 8, 2009, Pages 725-731

  Ikebe, Mio ^a   Kitaura, Yoshiki ^a   Nakamura, Masafumi ^a   Tanaka, Haruo ^a   Yamasaki, Akio ^a   Nagai, Shuntaro ^a   Wada, Junji ^a   Yanai, Kosuke ^a   Koga, Kenichiro ^a   Sato, Norihiro ^a   Kubo, Makoto ^a   Tanaka, Masao ^a   Onishi, Hideya ^a   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Invasion; MyD88; Pancreas; TLR4

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PYRROLIDINE DITHIOCARBAMATE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL ACTIVATION; CELL INVASION; COLON CANCER; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TARGET CELL;

CELL LINE, TUMOR; HUMANS; LIPOPOLYSACCHARIDES; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASM INVASIVENESS; NF-KAPPA B; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 73449146279     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21392     Document Type: Article

References (24)

1. Li D, Xie K, Wolff R, et al.: Pancreatic cancer. Lancet 2004;363: 1049-1057.
2. Balkwill F, Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 2001;357:539-545.
3. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002; 420:860-867.
4. Roder DM: The epidemiology of gastric cancer. Gastric Cancer 2002;5:5-11.
5. Karin M: Nuclear factor-κB in cancer development and progression. Nature 2006;441:431-436.
6. Karin M, Greten FR: NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749-759.
7. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-6866.
8. Luo JL, Kamata H, Karin M: IKK/NF-kappaB signaling: Balancing life and death-A new approach to cancer therapy. J Clin Invest 2005;115:2625-2632.
9. Wang W, Abbruzzese JL, Evans DB, et al.: The nuclear factorkappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5: 119-127.
10. Sasaki N, Morisaki T, Hashizume K, et al.: Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001;7:4136-4142.
11. Yamanaka N, Morisaki T, Nakashima H, et al.: Interleukin 1β enhances invasive ability of gastric carcinoma through nuclear factor-κB activation. Clin Cancer Res 2004;10:1853-1859.
12. Nakashima H, Nakamura M, Yamaguchi H, et al.: Nuclear factor-κB contributes to Hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res 2006; 66:7041-7049.
13. Kojima M, Morisaki T, Izuhara K, et al.: Lipopolysaccharide increases cyclo-oxygenase-2 in a colon carcinoma cell line through nuclear factor-κB activation. Oncogene 2000;19:1225-1231.
14. Akira S, Takeda K: Toll-like receptor signaling. Nat Rev Immunol 2004;4:499-511.
15. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
16. Kawai T, Akira S: Signaling to NF-κB by Toll-like receptors. Trends Mol Med 2007; 460-469.
17. Akira S: Toll-like receptor signaling. J Biol Chem 2003;278: 38105-38108.
18. Kelly MG, Alvero AB, Rui C, et al.: TLR4-signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006;66:3859-3868.
19. Kirkland T, Viriyakosol S, Perez-Perez GI, et al.: Helicobacter pylori lipopolysaccharide can activate 70Z/3 cells via CD14. Infect Immun 1997;65:604-608.
20. Diamond G, Russell J, Bevins C: Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci USA 1996;93: 5156-5160.
21. Wang W, Abbruzzese JL, Evans DB, et al.: Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene 1999;18:4554-4563.
22. Zhang H, Morisaki T, Matsunaga H, et al.: Protein-bound polysaccharide PSK inhibits tumor invasion by down-regulation of TGF-β and MMPs. Clin Exp Metastasis 2000;18:343-352.
23. Esteve PO, Chicoine E, Robledo O, et al.: Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-αin glioma cells via NF-κB. J Biol Chem 2002;277:35150-35155.
24. Hah N, Lee ST: An absolute role of the PKC-dependent NF-κB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2003;305: 428-433.